Phreesia Class Action Reminder for Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 55 minutes ago
0mins
Source: Globenewswire
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- How to Participate: Investors can visit the Rosen Law Firm website or call toll-free at 866-767-3653 for more information, ensuring they select qualified legal counsel to protect their rights and avoid inexperienced intermediary firms.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.650
Low
24.00
Averages
29.09
High
35.00
Current: 9.650
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Phreesia Class Action Reminder for Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- How to Participate: Investors can visit the Rosen Law Firm website or call toll-free at 866-767-3653 for more information, ensuring they select qualified legal counsel to protect their rights and avoid inexperienced intermediary firms.
See More
Multiple Companies Face Class Action Lawsuits
- Phreesia Lawsuit: Phreesia Inc. is accused of misleading investors during the period from May 2025 to March 2026 by claiming reliable long-term growth prospects, while in reality, its pharmaceutical marketing commitments were uncertain, potentially jeopardizing the 2027 revenue target.
- Sportradar Violations: Sportradar Group AG faces allegations of collaborating with black-market gambling operators from November 2024 to April 2026, despite claims of strict legal compliance, rendering its positive business outlook statements misleading and lacking a reasonable basis.
- Commvault Sales Issues: Commvault Systems Inc. is accused of failing to disclose the impact of sales types on its annual recurring revenue (ARR) growth from April 2025 to January 2026, leading to misleading positive statements about its business prospects.
- Veritone Financial Misconduct: Veritone, Inc. is charged with inaccurately recording revenue and costs from October 2025 to April 2026, necessitating a restatement of financial statements, which severely undermines investor confidence in the company's operations.
See More
Phreesia Faces Class Action Lawsuit Over Securities Violations
- Class Action Filed: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Phreesia, aiming to recover damages for investors who purchased securities between May 8, 2025, and March 30, 2026, indicating a significant loss of confidence in the company's future prospects.
- Allegations Detailed: The complaint alleges that Phreesia made materially false and misleading statements during the class period, failing to disclose slowing demand and diminished visibility into key revenue streams, which has eroded investor trust in the company's operations.
- Negative Market Reaction: The lawsuit's implications may exert downward pressure on Phreesia's stock price, leading investors to adopt a more cautious approach in future trading, thereby affecting the company's market performance and financing capabilities.
- Investor Rights Protection: Investors have until July 13, 2026, to apply as lead plaintiffs, with the law firm promising to provide legal support on a contingency fee basis, ensuring that investors can recover reasonable expenses only upon successful litigation.
See More
Phreesia Faces Class Action Lawsuit Amid Revenue Downgrade
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Phreesia, alleging securities fraud and other unlawful business practices, with investors needing to apply as Lead Plaintiff by July 13, 2026.
- Revenue Guidance Downgrade: On March 30, 2026, Phreesia significantly reduced its revenue growth projections for fiscal year 2027, citing macroeconomic factors such as worsening visibility and weaker pharmaceutical marketing commitments affecting its Network Solutions segment.
- Stock Price Plunge: Following the revenue downgrade, Phreesia's stock price fell by $3.03, or 26.56%, closing at $8.38 per share on March 31, 2026, indicating market pessimism regarding the company's future outlook.
- Legal Firm Background: Pomerantz LLP is a prominent law firm specializing in class action litigation, with a long history of recovering multimillion-dollar damages for victims of securities fraud, showcasing its expertise in handling complex securities cases.
See More
Phreesia Investors Class Action Reminder
- Lawsuit Background: On March 30, 2026, Phreesia announced significantly lowered revenue growth projections for fiscal 2027, resulting in a 26.6% drop in stock price to $8.38 per share the following day, causing substantial losses for investors.
- False Information Allegations: The complaint alleges that throughout the class period, the company misled investors by projecting confidence in its long-term growth outlook while downplaying risks associated with slowing growth in its Network Solutions segment.
- Class Action Deadline: Investors must file a lead plaintiff motion by July 13, 2026, to seek compensation for losses incurred during the class period, emphasizing the urgency for affected shareholders to act.
- Legal Consultation Information: Glancy Prongay Wolke & Rotter LLP offers legal consultation, encouraging investors to reach out via email or phone for further information to ensure their rights are protected.
See More
Reminder of Phreesia Stock Class Action Lawsuit
- Class Action Notification: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, or risk not being represented in the class action lawsuit.
- Fee Arrangement: Participants can receive compensation without any upfront costs through a contingency fee arrangement, which alleviates the financial burden on investors and encourages more affected shareholders to join the lawsuit.
- Lawsuit Background: The lawsuit alleges that Phreesia made false and misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, leading to investor losses when the truth emerged.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, ranked first in 2017 for the number of settlements, demonstrating its expertise and success in this legal domain.
See More
Phreesia Class Action Reminder for Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions, having recovered over $438 million for investors in 2019 alone, and was ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- How to Participate: Investors can visit the Rosen Law Firm website or call toll-free at 866-767-3653 for more information, ensuring they select qualified legal counsel to protect their rights and avoid inexperienced intermediary firms.
See More
Multiple Companies Face Class Action Lawsuits
- Phreesia Lawsuit: Phreesia Inc. is accused of misleading investors during the period from May 2025 to March 2026 by claiming reliable long-term growth prospects, while in reality, its pharmaceutical marketing commitments were uncertain, potentially jeopardizing the 2027 revenue target.
- Sportradar Violations: Sportradar Group AG faces allegations of collaborating with black-market gambling operators from November 2024 to April 2026, despite claims of strict legal compliance, rendering its positive business outlook statements misleading and lacking a reasonable basis.
- Commvault Sales Issues: Commvault Systems Inc. is accused of failing to disclose the impact of sales types on its annual recurring revenue (ARR) growth from April 2025 to January 2026, leading to misleading positive statements about its business prospects.
- Veritone Financial Misconduct: Veritone, Inc. is charged with inaccurately recording revenue and costs from October 2025 to April 2026, necessitating a restatement of financial statements, which severely undermines investor confidence in the company's operations.
See More
Phreesia Faces Class Action Lawsuit Over Securities Violations
- Class Action Filed: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Phreesia, aiming to recover damages for investors who purchased securities between May 8, 2025, and March 30, 2026, indicating a significant loss of confidence in the company's future prospects.
- Allegations Detailed: The complaint alleges that Phreesia made materially false and misleading statements during the class period, failing to disclose slowing demand and diminished visibility into key revenue streams, which has eroded investor trust in the company's operations.
- Negative Market Reaction: The lawsuit's implications may exert downward pressure on Phreesia's stock price, leading investors to adopt a more cautious approach in future trading, thereby affecting the company's market performance and financing capabilities.
- Investor Rights Protection: Investors have until July 13, 2026, to apply as lead plaintiffs, with the law firm promising to provide legal support on a contingency fee basis, ensuring that investors can recover reasonable expenses only upon successful litigation.
See More
Phreesia Faces Class Action Lawsuit Amid Revenue Downgrade
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Phreesia, alleging securities fraud and other unlawful business practices, with investors needing to apply as Lead Plaintiff by July 13, 2026.
- Revenue Guidance Downgrade: On March 30, 2026, Phreesia significantly reduced its revenue growth projections for fiscal year 2027, citing macroeconomic factors such as worsening visibility and weaker pharmaceutical marketing commitments affecting its Network Solutions segment.
- Stock Price Plunge: Following the revenue downgrade, Phreesia's stock price fell by $3.03, or 26.56%, closing at $8.38 per share on March 31, 2026, indicating market pessimism regarding the company's future outlook.
- Legal Firm Background: Pomerantz LLP is a prominent law firm specializing in class action litigation, with a long history of recovering multimillion-dollar damages for victims of securities fraud, showcasing its expertise in handling complex securities cases.
See More
Phreesia Investors Class Action Reminder
- Lawsuit Background: On March 30, 2026, Phreesia announced significantly lowered revenue growth projections for fiscal 2027, resulting in a 26.6% drop in stock price to $8.38 per share the following day, causing substantial losses for investors.
- False Information Allegations: The complaint alleges that throughout the class period, the company misled investors by projecting confidence in its long-term growth outlook while downplaying risks associated with slowing growth in its Network Solutions segment.
- Class Action Deadline: Investors must file a lead plaintiff motion by July 13, 2026, to seek compensation for losses incurred during the class period, emphasizing the urgency for affected shareholders to act.
- Legal Consultation Information: Glancy Prongay Wolke & Rotter LLP offers legal consultation, encouraging investors to reach out via email or phone for further information to ensure their rights are protected.
See More
Reminder of Phreesia Stock Class Action Lawsuit
- Class Action Notification: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, or risk not being represented in the class action lawsuit.
- Fee Arrangement: Participants can receive compensation without any upfront costs through a contingency fee arrangement, which alleviates the financial burden on investors and encourages more affected shareholders to join the lawsuit.
- Lawsuit Background: The lawsuit alleges that Phreesia made false and misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, leading to investor losses when the truth emerged.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, ranked first in 2017 for the number of settlements, demonstrating its expertise and success in this legal domain.
See More
